Murdoch Children’s Research Institute in Australia & McGill University Health Centre’s Division of Infectious Diseases and Chronic Viral Illness to benefit from Tilray’s support
“The SAFE Banking Act would go a long way toward improving safety, transparency, access, and justice in the cannabis industry,”
Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis
Medical cannabis (MC) is commonly claimed to be an effective treatment for chronic or refractory pain. With interest in MC in the United States growing, as evidenced by the 29 states and 3 US districts that now have public MC programs, the need for clinical evidence supporting this claim has never been greater. After 3 months treatment, MC improved quality of life, reduced pain and opioid use, and lead to cost savings. Large randomized clinical trials are warranted to further evaluate the role of MC in the treatment of chronic pain.